玻璃体内注射贝伐单抗治疗视力低于20/200的晚期新生血管性年龄相关性黄斑变性 - Suppr

Intravitreal bevacizumab in advanced-stage neovascular age-related macular degeneration with visual acuity lower than 20/200.

作者信息

Parodi Maurizio Battaglia, Cascavilla Marialucia, Papayannis Alexandros, Kontadakis Dimitrios Stelios, Bandello Francesco, Iacono Pierluigi

出版信息

Arch Ophthalmol. 2012 Jul;130(7):934-5. doi: 10.1001/archophthalmol.2011.2617.

DOI:10.1001/archophthalmol.2011.2617

PMID:22776937

Abstract

摘要

相似文献

Intravitreal bevacizumab in advanced-stage neovascular age-related macular degeneration with visual acuity lower than 20/200.玻璃体内注射贝伐单抗治疗视力低于20/200的晚期新生血管性年龄相关性黄斑变性

Arch Ophthalmol. 2012 Jul;130(7):934-5. doi: 10.1001/archophthalmol.2011.2617.

Retreatment with anti-vascular endothelial growth factor therapy based on changes in visual acuity after initial stabilization of neovascular age-related macular degeneration: 3-year follow-up results.基于新生血管性年龄相关性黄斑变性初始稳定后视力变化的抗血管内皮生长因子治疗的再治疗：3 年随访结果。

Retina. 2012 Sep;32(8):1471-9. doi: 10.1097/IAE.0b013e318236e805.

Treat-and-extend bevacizumab for neovascular age-related macular degeneration: the importance of baseline characteristics.用于治疗新生血管性年龄相关性黄斑变性的贝伐单抗持续给药方案：基线特征的重要性

Retina. 2014 May;34(5):846-52. doi: 10.1097/IAE.0000000000000033.

Efficacy of 12-month treatment of neovascular age-related macular degeneration with intravitreal bevacizumab based on individually determined injection strategies after three consecutive monthly injections.基于连续 3 个月每月注射 1 次后的个体化注射策略，玻璃体内注射贝伐单抗治疗新生血管性年龄相关性黄斑变性 12 个月的疗效。

Acta Ophthalmol. 2011 Nov;89(7):647-53. doi: 10.1111/j.1755-3768.2009.01740.x. Epub 2009 Oct 23.

Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact.贝伐单抗治疗新生血管性年龄相关性黄斑变性的治疗和延长方案：临床和经济影响。

Am J Ophthalmol. 2012 Mar;153(3):468-473.e1. doi: 10.1016/j.ajo.2011.08.011. Epub 2011 Oct 11.

Bevacizumab for neovascular age-related macular degeneration in China.贝伐单抗治疗中国新生血管性年龄相关性黄斑变性。

Ophthalmology. 2012 Oct;119(10):2087-93. doi: 10.1016/j.ophtha.2012.05.016. Epub 2012 Jul 20.

Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration.抗血管内皮生长因子药物的临床应用及新生血管性年龄相关性黄斑变性的疾病监测。

Am J Ophthalmol. 2014 Apr;157(4):825-833.e1. doi: 10.1016/j.ajo.2013.12.018. Epub 2013 Dec 31.

Fibrovascular pigment epithelial detachment is a risk factor for long-term visual decay in neovascular age-related macular degeneretion.纤维血管性色素上皮脱离是新生血管性年龄相关性黄斑变性长期视力衰退的一个危险因素。

Retina. 2014 Sep;34(9):1767-73. doi: 10.1097/IAE.0000000000000188.

Systemic beta-blockers may reduce the need for repeated intravitreal injections in patients with wet age-related macular degeneration treated by bevacizumab.系统使用β受体阻滞剂可能会减少湿性年龄相关性黄斑变性患者接受贝伐单抗治疗时重复玻璃体内注射的需求。

Retina. 2013 Mar;33(3):508-12. doi: 10.1097/IAE.0b013e3182695ba0.

A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration.一项前瞻性、观察性、开放标签、多中心研究，旨在调查雷珠单抗在新生血管性年龄相关性黄斑变性患者中的日常治疗实践。

Acta Ophthalmol. 2015 Mar;93(2):126-33. doi: 10.1111/aos.12610. Epub 2014 Dec 9.

引用本文的文献

A systematic review and meta-analysis of the effect of intravitreal VEGF inhibitors on cardiorenal outcomes.一项关于玻璃体内血管内皮生长因子抑制剂对心肾结局影响的系统评价和荟萃分析。

Nephrol Dial Transplant. 2023 Jun 30;38(7):1666-1681. doi: 10.1093/ndt/gfac305.

Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.抗血管内皮生长因子用于治疗新生血管性年龄相关性黄斑变性。

Cochrane Database Syst Rev. 2019 Mar 4;3(3):CD005139. doi: 10.1002/14651858.CD005139.pub4.

Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.抗血管内皮生长因子用于治疗新生血管性年龄相关性黄斑变性。

Cochrane Database Syst Rev. 2014 Aug 29;8(8):CD005139. doi: 10.1002/14651858.CD005139.pub3.

Management of significant reactivation of old disciform scars in wet age-related macular degeneration.湿性年龄相关性黄斑变性中陈旧盘状瘢痕的显著再激活的处理。

BMC Ophthalmol. 2014 Jun 25;14:82. doi: 10.1186/1471-2415-14-82.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Intravitreal bevacizumab in advanced-stage neovascular age-related macular degeneration with visual acuity lower than 20/200.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献